Does MOMELOTINIB Cause Product use issue? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Product use issue have been filed in association with MOMELOTINIB (Ojjaara). This represents 1.3% of all adverse event reports for MOMELOTINIB.
12
Reports of Product use issue with MOMELOTINIB
1.3%
of all MOMELOTINIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product use issue From MOMELOTINIB?
Of the 12 reports, 1 (8.3%) required hospitalization.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOMELOTINIB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does MOMELOTINIB Cause?
Thrombocytopenia (89)
Death (77)
Drug ineffective (75)
Anaemia (59)
Diarrhoea (51)
Myelofibrosis (51)
Condition aggravated (49)
Dizziness (41)
Pneumonia (41)
Fatigue (39)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which MOMELOTINIB Alternatives Have Lower Product use issue Risk?
MOMELOTINIB vs MOMETASONE
MOMELOTINIB vs MOMETASONE FUROATE
MOMELOTINIB vs MOMETASONE FUROATE\OLOPATADINE
MOMELOTINIB vs MONOMETHYL
MOMELOTINIB vs MONTELUKAST